Shandong Weigao Blood Purification Products Co., Ltd.

¥34.86As of Sun 8 Nov 2026, 12:00 UTC
SSE:603014Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 1.49%
ROE 11.26%
Medical Devices
Beta (5Y) —
PE TTM 21.40
TSR TTM (7.78%)
Mkt cap ¥14.56B
ROIC 16.42%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥33
(4.49%)
(32.12%)
Hold 7|2|8|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.41
0.39
0.38
0.39
12.03%
0.44%
(0.79%)
2.74%
Revenue¥B
1.126
1.119
1.170
1.199
4.94%
2.82%
9.09%
6.27%
Peers (US$2.183B)
Cap (US$)
PE
2.553B
26.82x
1.952B
42.28x
2.351B
31.01x
Capital
TTM
5Y
10Y
Leveragex
0.945
0.161
0.140
EBIT/Intx
2.597
0.137
0.125
Own earn%
154.05
214.15
204.68
Sh yield%
40.99
51.13
54.90
Owners
Insiders/Inst%
14.49
83.94
Short interest%
4.59
SBC / revenue%
5.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
25–29
$1 testx
—
Incr. ROIC%
11